Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer

Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer

Objective: To guide the optimal selection among first-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in clinical practice. This review attempted to provide a thorough comparison among three first-generation EGFR-TKIs, namely icotinib, erlotinib, and gefitinib, wit...

Full description

Bibliographic Details
Main Authors: Jun Ni, Li Zhang
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Advanced Nonsmall Cell Lung Cancer; Epithelial Growth Factor Receptor; Optimal Selection; Tyrosine Kinase Inhibitors
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=3;spage=332;epage=340;aulast=Ni

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=3;spage=332;epage=340;aulast=Ni

Similar Items